Watch a replay of the HPS Corporate Lending Fund First Quarter 2023 Shareholder Update
Portfolio Companies7
Company Name
|
Industry
|
Investment Type
|
Reference Rate & Spread
|
Par Amount (thousands)
|
Amortized Cost (thousands)
|
Fair Value (thousands)
|
% of Total Portfolio
|
---|---|---|---|---|---|---|---|
ABB/CON-CISE Optical Group LLC (ABB Optical) | Medical Equipment and Services | 1st Lien Senior Secured | P + 6.50% | $ 2,358 | $ 2,192 | $ 2,106 | 0.00% |
Alera Group, Inc. | Non-life Insurance | 1st Lien Senior Secured | SF + 6.00% | $ 78,273 | $ 78,056 | $ 74,976 | 1.10% |
Alliant Holdings Intermediate LLC / Alliant Holdings Co-Issuer (Alliant Ins Services Inc.) | Non-life Insurance | Unsecured Debt | 6.75% | $ 6,255 | $ 5,658 | $ 5,819 | 0.10% |
Alliant Holdings Intermediate, LLC (Alliant Ins Services Inc.) | Non-life Insurance | 1st Lien Senior Secured | L + 3.50% | $ 17,802 | $ 17,631 | $ 17,646 | 0.30% |
Alliant Holdings Intermediate, LLC (Alliant Ins Services Inc.) | Non-life Insurance | 1st Lien Senior Secured | SF + 3.50% | $ 495 | $ 487 | $ 491 | 0.00% |
AmWINS Group, Inc. | Non-life Insurance | 1st Lien Senior Secured | L + 2.25% | $ 4,633 | $ 4,609 | $ 4,585 | 0.10% |
Amynta Agency Borrower Inc (Amynta) | Non-life Insurance | 1st Lien Senior Secured | SF + 5.00% | $ 20,217 | $ 19,604 | $ 19,484 | 0.30% |
Galway Borrower LLC | Non-life Insurance | 1st Lien Senior Secured | SF + 5.25% | $ 63,645 | $ 60,909 | $ 58,834 | 0.90% |
HIGGINBOTHAM INSURANCE AGENCY, INC. | Non-life Insurance | 1st Lien Senior Secured | L + 5.25% | $ 9,900 | $ 9,802 | $ 9,682 | 0.10% |
HUB International Limited | Non-life Insurance | 1st Lien Senior Secured | L + 3.25% | $ 21,543 | $ 21,378 | $ 21,520 | 0.30% |
Integrity Marketing Acquisition LLC (Integrity Marketing Group) | Non-life Insurance | 1st Lien Senior Secured | SF + 6.02% | $ 78,253 | $ 73,442 | $ 72,679 | 1.10% |
Jones Deslauriers Insurance Management Inc. (Navacord Inc.) | Non-life Insurance | 1st Lien Senior Secured | 8.50% | $ 7,336 | $ 7,336 | $ 7,611 | 0.10% |
Patriot Growth Insurance Services, LLC | Non-life Insurance | 1st Lien Senior Secured | L + 5.50% | $ 8,063 | $ 7,108 | $ 7,105 | 0.10% |
Patriot Growth Insurance Services, LLC | Non-life Insurance | 1st Lien Senior Secured | L + 5.75% | $ 18,286 | $ 4,010 | $ 4,025 | 0.10% |
RSC Acquisition, Inc. (Business Risk Strategies Ltd) | Non-life Insurance | 1st Lien Senior Secured | SF + 5.50% | $ 54,778 | $ 35,423 | $ 34,745 | 0.50% |
Trupanion, Inc. | Non-life Insurance | 1st Lien Senior Secured | SF + 5.00% | $ 53,559 | $ 37,590 | $ 36,622 | 0.60% |
Puma Buyer LLC (PANTHERx Rare) | Personal Care, Drug and Grocery Stores | 1st Lien Senior Secured | SF + 5.50% | $ 61,845 | $ 57,821 | $ 61,265 | 0.90% |
Vermont Aus Pty Ltd (Greencross Vets) | Personal Care, Drug and Grocery Stores | 1st Lien Senior Secured | B + 5.75% | A$ 35,393 | $ 25,851 | $ 22,663 | 0.30% |
Vermont Aus Pty Ltd (Greencross Vets) | Personal Care, Drug and Grocery Stores | 1st Lien Senior Secured | SF + 5.65% | $ 25,988 | $ 25,430 | $ 24,902 | 0.40% |
DAPHNE S.P.A. (Dainese) | Personal Goods | 1st Lien Senior Secured | E + 6.25% | € 49,333 | $ 43,045 | $ 42,871 | 0.60% |
Spanx, LLC | Personal Goods | 1st Lien Senior Secured | L + 5.25% | $ 34,625 | $ 30,524 | $ 29,639 | 0.40% |
CPI Buyer, LLC (Antylia Scientific) | Pharmaceuticals and Biotechnology | 1st Lien Senior Secured | L + 5.50% | $ 2,115 | $ (32) | $ (26) | 0.00% |
CPI Buyer, LLC (Antylia Scientific) | Pharmaceuticals and Biotechnology | 1st Lien Senior Secured | SF + 5.50% | $ 27,950 | $ 26,139 | $ 26,026 | 0.40% |
Dolcetto HoldCo S.P.A. (Doc Generici S.r.l.) | Pharmaceuticals and Biotechnology | 1st Lien Senior Secured | E + 6.50% | € 90,700 | $ 79,921 | $ 87,200 | 1.30% |
Gusto Aus Bidco Pty Ltd (iNova Pharmaceuticals) | Pharmaceuticals and Biotechnology | 1st Lien Senior Secured | B + 6.50% | A$ 130,605 | $ 73,777 | $ 78,869 | 1.20% |
Engage with HLEND
Start HereEngage with HLEND
Financial advisors can submit an inquiry using this form or engage with HPS at hlend@hpspartners.com. Individual investors should contact their financial advisor for more information.
Footnotes
- Computed as (a) the annual stated interest rate or yield plus the annual accretion of discounts or less the annual amortization of premiums, as applicable, on accruing debt included in such securities, divided by (b) total debt investments at fair value included in such securities. Actual yields earned over the life of each investment could differ materially from the yields presented above.
- Private Investments represents level 3 investments in the investment portfolio where inputs to the valuation methodology are unobservable and significant to overall fair value measurement. Measured as total fair value of investments.
- Measured as the fair value of investments for each category relative to the total fair value of investments. Totals may not sum due to rounding.
- Measured as the fair value of debt investments.
- Calculated with respect to all private investments, including investments for which fair value is determined by HPS (in its capacity as the investment manager of HLEND) (with assistance, at least quarterly, from a third-party valuation firm, and overseen by HLEND’s Board of Trustees) and, in the case of weighted average EBITDA only, excludes investments where net debt to EBITDA may not be the appropriate measure of credit risk. Figures are derived from the financial statements most recently obtained by the Adviser. Weighted average EBITDA is weighted based on the fair value of our total applicable private debt investments.
- Other include structured finance investments.
- All figures are as of March 31, 2023 unless otherwise indicated. % of total portfolio shown above is measured as total fair value of investments.